Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 113
  2. 114
  3. 115
  4. 116
  5. 117
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Zolbetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5047UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Zolbetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5047UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Adalimumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4001-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Adalimumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4001-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4002-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4002-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4003-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4003-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4004-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4004-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Eculizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4005-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Eculizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4005-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Infliximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4006-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Infliximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4006-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Matuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4007-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Matuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4007-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Nimotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4008-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Nimotuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4008-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Nivolumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4009-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Nivolumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4009-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Omalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4010-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Omalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4010-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Rituximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4011-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Rituximab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu Humanized ICH4011-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Name Preis
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Zolbetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Zolbetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Zolbetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Zolbetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Adalimumab Biosimilar -­ Research Grade Anmelden Adalimumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Adalimumab Biosimilar -­ Research Grade Anmelden Adalimumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Alemtuzumab Biosimilar -­ Research Grade Anmelden Alemtuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Alemtuzumab Biosimilar -­ Research Grade Anmelden Alemtuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Bevacizumab Biosimilar -­ Research Grade Anmelden Bevacizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Bevacizumab Biosimilar -­ Research Grade Anmelden Bevacizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Cetuximab Biosimilar -­ Research Grade Anmelden Cetuximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Cetuximab Biosimilar -­ Research Grade Anmelden Cetuximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Eculizumab Biosimilar -­ Research Grade Anmelden Eculizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Eculizumab Biosimilar -­ Research Grade Anmelden Eculizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Infliximab Biosimilar -­ Research Grade Anmelden Infliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Infliximab Biosimilar -­ Research Grade Anmelden Infliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Matuzumab Biosimilar -­ Research Grade Anmelden Matuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Matuzumab Biosimilar -­ Research Grade Anmelden Matuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Nimotuzumab Biosimilar -­ Research Grade Anmelden Nimotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Nimotuzumab Biosimilar -­ Research Grade Anmelden Nimotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Nivolumab Biosimilar -­ Research Grade Anmelden Nivolumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Nivolumab Biosimilar -­ Research Grade Anmelden Nivolumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Omalizumab Biosimilar -­ Research Grade Anmelden Omalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Omalizumab Biosimilar -­ Research Grade Anmelden Omalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar
Rituximab Biosimilar -­ Research Grade Anmelden Rituximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 1 mg
Lieferbar
Rituximab Biosimilar -­ Research Grade Anmelden Rituximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host Humanized
ArtNr.
Menge 100 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 113
  2. 114
  3. 115
  4. 116
  5. 117
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top